Company Filing History:
1 out of 1,147 
1 out of 338 Years Active: 2022
Title: **Innovative Contributions of Miseon Ryu in Cardiovascular Treatment**
Introduction
Miseon Ryu is a prominent inventor based in Gyeongsangnam-do, South Korea. With a focus on addressing critical health issues, he has made significant contributions to the field of cardiovascular medicine. His innovative work has led to the development of a patented compound that has the potential to improve medical treatments for cardiovascular diseases.
Latest Patents
Miseon Ryu holds one patent for a novel N-acylurea derivative and the composition comprising it for the prevention or treatment of cardiovascular disease. This groundbreaking invention details the use of the N-acylurea derivative in a pharmaceutical composition aimed at inhibiting platelet aggregation by targeting the activity of talin in the intracellular matrix. This mechanism offers a promising approach to preventing or treating cardiovascular diseases.
Career Highlights
Throughout his career, Miseon Ryu has established a strong foundation in research and innovation. He has been affiliated with the Korea University Research and Business Foundation and the Kyungpook National University Industry-Academic Cooperation Foundation, where he has likely collaborated with other experts in the field and contributed to various research projects.
Collaborations
Miseon Ryu has worked alongside notable colleagues, including Soon Jun Hong and Chung Ho Kim. These collaborations have not only enhanced his research capabilities but have also fostered an environment of shared knowledge and innovation in cardiovascular research.
Conclusion
Miseon Ryu's work exemplifies the spirit of innovation necessary for advancing medical treatments. By focusing on the prevention and treatment of cardiovascular diseases, his contributions through the patented N-acylurea derivative showcase the significant role inventors play in the medical field. His ongoing commitment to research and collaboration will undoubtedly lead to further advancements in health care solutions.